Health Care & Life Sciences » Pharmaceuticals | Shenzhen Hepalink Pharmaceutical Co. Ltd.

Shenzhen Hepalink Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Shenzhen Hepalink Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Golden Eagle Stable Growth Equity Fund
9,000,000
0.72%
-1,361,341
12.81%
12/31/2017
1,696,860
0.14%
-391,199
0.93%
12/31/2017
623,400
0.05%
-256,600
0.99%
12/31/2017
China SME ETF
496,542
0.04%
-31,400
0.44%
12/31/2017
Vanguard Emerging Markets Stock Index Fund
489,180
0.04%
0
0%
07/31/2018
226,888
0.02%
-94,600
2.29%
12/31/2017
226,788
0.02%
26,400
0.43%
12/31/2017
111,068
0.01%
-86,000
0.11%
12/31/2017
100,000
0.01%
100,000
3.89%
12/31/2017
89,928
0.01%
3,000
0.66%
09/06/2018

About Shenzhen Hepalink Pharmaceutical Co.

View Profile
Address
No. 21 Langshan Road
Shenzhen Guangdong 518057
China
Employees -
Website http://www.hepalink.com
Updated 07/08/2019
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. is engaged in the research, production and distribution of heparin sodium bulk drugs. It offers heparin sodium products, including Food and Drug Administration (FDA) grade heparin sodium ingredients and ordinary grade heparin sodium ingredients. The company was founded by Li Tan, Li Li and Shan Yu on April 21, 1998 and is headquartered in Shenzhen, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.